Christoph Tabeling
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Christoph Tabeling has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Leigh Matthew Marsh
Otto Loewi Research Center, Lung Research Cluster, Medical University of Graz, Graz, Austria
3 shared publications - Martin Witzenrath
Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203 Berlin, Germany
3 shared publications - Andrea Olschewski
Experimental Anaesthesiology, Department of Anaesthesiology and Intensive Care Medicine, Medical University of Graz, Graz, Austria
2 shared publications - Anna Birnhuber
Otto Loewi Research Centre, Lung Research Group, Medical University of Graz, Graz, Austria
2 shared publications - Chandran Nagaraj
Division of Pulmonology, Department of Internal Medicine, Lung Research Cluster, Medical University of Graz, Graz, Austria
2 shared publications - Grazyna Kwapiszewska
Otto Loewi Research Center, Lung Research Cluster, Medical University of Graz, Graz, Austria
2 shared publications
Latest Publications
- Open Access
- 21 August 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (1)
ET B receptor deficiency amplifies allergic airway inflammation and hyperresponsiveness
Background: Endothelin-1 (ET-1) is a proinflammatory mediator that plays a crucial role in regulating airway tone by activating G protein-coupled endothelin receptors A (ET A ) and B (ET B ). The endothelin system has been linked to asthma, but the impact of ET B receptor deficiency on allergic airway inflammation remains uncharted. This study explores how the endothelin system influences allergic airway inflammation and hyperresponsiveness. Methods: We used rescued ET B receptor-deficient (ET B −/− ) mice to obviate lethal inherited Hirschsprung disease, prepro-ET-1 overexpressing ( pre ET tg ), and wild-type (WT) mice. Basal airway resistance and responsiveness to broncho-constrictive stimuli were assessed in isolated, perfused and ventilated lungs of naïve mice. Additionally, we analysed the humoral immune response and airway hyperresponsiveness following induction of type 2 airway inflammation induced by systemic ovalbumin (OVA) sensitisation and repeated airway challenge with aerosolised OVA. Results: Naïve ET B −/− mice exhibited significantly heightened airway responsiveness compared to naïve WT mice. After OVA sensitisation and challenge, ET B −/− mice displayed increased OVA-specific immunoglobulin E levels, intensified allergic airway inflammation and hyperresponsiveness compared to WT mice. Conversely, pre ET tg mice displayed reduced immunoglobulin E levels, airway inflammation and hyperresponsiveness. Conclusion: Our findings suggest ET B receptors have a protective role in asthma-associated allergic airway inflammation and hyperresponsiveness. The increased asthma phenotype in sensitised and challenged ET B −/− mice is attributed to ET B -specific immunomodulatory mechanisms, rather than to elevated levels of ET-1 resulting from impaired ET B -mediated ET-1 clearance. This conclusion is supported by the diminished asthma-phenotype observed in sensitised and challenged pre ET tg mice. Therefore, adjusting endothelin signalling could offer a promising approach to managing asthma.
- 21 August 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (1)
Open AccessET B receptor deficiency amplifies allergic airway inflammation and hyperresponsiveness
Background: Endothelin-1 (ET-1) is a proinflammatory mediator that plays a crucial role in regulating airway tone by activating G protein-coupled endothelin receptors A (ET A ) and B (ET B ). The endothelin system has been linked to asthma, but the impact of ET B receptor deficiency on allergic airway inflammation remains uncharted. This study explores how the endothelin system influences allergic airway inflammation and hyperresponsiveness. Methods: We used rescued ET B receptor-deficient (ET B −/− ) mice to obviate lethal inherited Hirschsprung disease, prepro-ET-1 overexpressing ( pre ET tg ), and wild-type (WT) mice. Basal airway resistance and responsiveness to broncho-constrictive stimuli were assessed in isolated, perfused and ventilated lungs of naïve mice. Additionally, we analysed the humoral immune response and airway hyperresponsiveness following induction of type 2 airway inflammation induced by systemic ovalbumin (OVA) sensitisation and repeated airway challenge with aerosolised OVA. Results: Naïve ET B −/− mice exhibited significantly heightened airway responsiveness compared to naïve WT mice. After OVA sensitisation and challenge, ET B −/− mice displayed increased OVA-specific immunoglobulin E levels, intensified allergic airway inflammation and hyperresponsiveness compared to WT mice. Conversely, pre ET tg mice displayed reduced immunoglobulin E levels, airway inflammation and hyperresponsiveness. Conclusion: Our findings suggest ET B receptors have a protective role in asthma-associated allergic airway inflammation and hyperresponsiveness. The increased asthma phenotype in sensitised and challenged ET B −/− mice is attributed to ET B -specific immunomodulatory mechanisms, rather than to elevated levels of ET-1 resulting from impaired ET B -mediated ET-1 clearance. This conclusion is supported by the diminished asthma-phenotype observed in sensitised and challenged pre ET tg mice. Therefore, adjusting endothelin signalling could offer a promising approach to managing asthma.
- 1 March 2025
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 328 (3) , L413-L429
Pulmonary vascular remodeling in Fra-2 transgenic mice is driven by type 2 inflammation and accompanied by pulmonary vascular hyperresponsiveness
In patients suffering from systemic sclerosis (SSc), pulmonary arterial hypertension (PAH) is a life-threatening complication linked to immune dysregulation. Preclinical analyses in Fos-related antigen-2 (Fra-2) transgenic (TG) mice, a model of SSc-PAH, identify type 2 inflammation as a key driver of vascular remodeling. Anti-inflammatory treatment targeting type 2 inflammation via IL-13 neutralizing antibodies improved pulmonary vascular remodeling. Thus, type 2-specific anti-inflammatory treatment may be a promising therapeutic approach in SSc-PAH.
- 1 March 2025
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 328 (3) , L413-L429
Pulmonary vascular remodeling in Fra-2 transgenic mice is driven by type 2 inflammation and accompanied by pulmonary vascular hyperresponsiveness
In patients suffering from systemic sclerosis (SSc), pulmonary arterial hypertension (PAH) is a life-threatening complication linked to immune dysregulation. Preclinical analyses in Fos-related antigen-2 (Fra-2) transgenic (TG) mice, a model of SSc-PAH, identify type 2 inflammation as a key driver of vascular remodeling. Anti-inflammatory treatment targeting type 2 inflammation via IL-13 neutralizing antibodies improved pulmonary vascular remodeling. Thus, type 2-specific anti-inflammatory treatment may be a promising therapeutic approach in SSc-PAH.
- 1 May 2021
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 320 (5) , L916-L925
Pulmonary fibrosis in Fra-2 transgenic mice is associated with decreased numbers of alveolar macrophages and increased susceptibility to pneumococcal pneumonia
Idiopathic pulmonary fibrosis (IPF) is a deadly condition characterized by progressive respiratory dysfunction. Exacerbations due to airway infections are believed to promote disease progression, and presence of Streptococcus in the lung microbiome has been associated with the progression of IPF and mortality. The aim of this study was to analyze the effect of lung fibrosis on susceptibility to pneumococcal pneumonia and bacteremia. The effects of subclinical (low dose) infection with Streptococcus pneumoniae were studied in a well characterized fos-related antigen-2 (Fra-2) transgenic (TG) mouse model of spontaneous, progressive pulmonary fibrosis. Forty-eight hours after transnasal infection with S. pneumoniae, bacterial load was assessed in lung tissue, bronchoalveolar lavage (BAL), blood, and spleen. Leukocyte subsets and cytokine levels were analyzed in BAL and blood. Lung compliance and arterial blood gases were assessed. In contrast to wildtype mice, low dose lung infection with S. pneumoniae in Fra-2 TG mice resulted in substantial pneumonia including weight loss, increased lung bacterial load, and bacteremia. BAL alveolar macrophages were reduced in Fra-2 TG mice compared to the corresponding WT mice. Proinflammatory cytokines and chemokines (IL-1β, IL-6, TNF-α, and CXCL1) were elevated upon infection in BAL supernatant and plasma of Fra-2 TG mice. Lung compliance was decreased in Fra-2 TG mice following low dose infection with S. pneumoniae. Pulmonary fibrosis increases susceptibility to pneumococcal pneumonia and bacteremia possibly via impaired alveolar bacterial clearance.
- 1 May 2021
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 320 (5) , L916-L925
Pulmonary fibrosis in Fra-2 transgenic mice is associated with decreased numbers of alveolar macrophages and increased susceptibility to pneumococcal pneumonia
Idiopathic pulmonary fibrosis (IPF) is a deadly condition characterized by progressive respiratory dysfunction. Exacerbations due to airway infections are believed to promote disease progression, and presence of Streptococcus in the lung microbiome has been associated with the progression of IPF and mortality. The aim of this study was to analyze the effect of lung fibrosis on susceptibility to pneumococcal pneumonia and bacteremia. The effects of subclinical (low dose) infection with Streptococcus pneumoniae were studied in a well characterized fos-related antigen-2 (Fra-2) transgenic (TG) mouse model of spontaneous, progressive pulmonary fibrosis. Forty-eight hours after transnasal infection with S. pneumoniae, bacterial load was assessed in lung tissue, bronchoalveolar lavage (BAL), blood, and spleen. Leukocyte subsets and cytokine levels were analyzed in BAL and blood. Lung compliance and arterial blood gases were assessed. In contrast to wildtype mice, low dose lung infection with S. pneumoniae in Fra-2 TG mice resulted in substantial pneumonia including weight loss, increased lung bacterial load, and bacteremia. BAL alveolar macrophages were reduced in Fra-2 TG mice compared to the corresponding WT mice. Proinflammatory cytokines and chemokines (IL-1β, IL-6, TNF-α, and CXCL1) were elevated upon infection in BAL supernatant and plasma of Fra-2 TG mice. Lung compliance was decreased in Fra-2 TG mice following low dose infection with S. pneumoniae. Pulmonary fibrosis increases susceptibility to pneumococcal pneumonia and bacteremia possibly via impaired alveolar bacterial clearance.
- Open Access
- 20 July 2017
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 50 (1) , 1601651
Hypoxic vascular response and ventilation/perfusion matching in end-stage COPD may depend on p22phox
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease in which the amount of emphysema and airway disease may be very different between individuals, even in end-stage disease. Emphysema formation may be linked to the involvement of the small pulmonary vessels. The NAPDH oxidase (Nox) family is emerging as a key disease-related factor in vascular diseases, but currently its role in hypoxia-induced pulmonary remodelling in COPD remains unclear.Here we investigate the role of p22phox, a regulatory subunit of Nox, in COPD lungs, hypoxic pulmonary vasoconstriction (HPV), hypoxia-induced pulmonary vascular remodelling and pulmonary hypertension.In COPD, compared to control lungs, p22phox expression was significantly reduced. The expression was correlated positively with mean pulmonary arterial pressure and oxygenation index and negatively with the diffusing capacity of the lung for carbon monoxide (p-/-mice, HPV was significantly impaired. In the chronic hypoxic setting, lack of p22phox was associated with improved right ventricular function and decreased pulmonary vascular remodelling.p22phox-dependent Nox plays an important role in the COPD phenotype, by its action on phase II HPV and chronic vascular remodelling.
- 20 July 2017
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 50 (1) , 1601651
Open AccessHypoxic vascular response and ventilation/perfusion matching in end-stage COPD may depend on p22phox
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease in which the amount of emphysema and airway disease may be very different between individuals, even in end-stage disease. Emphysema formation may be linked to the involvement of the small pulmonary vessels. The NAPDH oxidase (Nox) family is emerging as a key disease-related factor in vascular diseases, but currently its role in hypoxia-induced pulmonary remodelling in COPD remains unclear.Here we investigate the role of p22phox, a regulatory subunit of Nox, in COPD lungs, hypoxic pulmonary vasoconstriction (HPV), hypoxia-induced pulmonary vascular remodelling and pulmonary hypertension.In COPD, compared to control lungs, p22phox expression was significantly reduced. The expression was correlated positively with mean pulmonary arterial pressure and oxygenation index and negatively with the diffusing capacity of the lung for carbon monoxide (p-/-mice, HPV was significantly impaired. In the chronic hypoxic setting, lack of p22phox was associated with improved right ventricular function and decreased pulmonary vascular remodelling.p22phox-dependent Nox plays an important role in the COPD phenotype, by its action on phase II HPV and chronic vascular remodelling.
- 1 November 2011
- Published by Elsevier in Life Sciences
- Vol. 89 (21-22) , 806-811
Expression profile of the sphingosine kinase signalling system in the lung of patients with chronic obstructive pulmonary disease
- 1 November 2011
- Published by Elsevier in Life Sciences
- Vol. 89 (21-22) , 806-811
Expression profile of the sphingosine kinase signalling system in the lung of patients with chronic obstructive pulmonary disease
- 3 February 2011
- Published by Georg Thieme Verlag KG in Pneumologie
- Vol. 65 (02) , A11
The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia1
Streptococcus pneumoniae is a leading cause of pneumonia, meningitis and sepsis. While certain pneumococcal serotypes are associated with nasopharyngeal colonization, infections in patients with underlying diseases, and higher mortality when causing pneumonia, serotypes 1, 7F and 8 are predominantly found in invasive diseases that, however, show lower case-fatality rates. We tested the hypotheses that the innate immune inflammasome pathway is involved in fighting pneumococcal pneumonia, and that some invasive pneumococcal serotypes are not recognized by this pathway. We show that human and murine mononuclear cells responded to S. pneumoniae expressing hemolytic pneumolysin by producing IL-1β. This IL-1β production depended on the ‘NLR family, pyrin domain containing 3’ (NLRP3) inflammasome. Serotype 1, serotype 8 and serotype 7F bacteria producing toxins with no or reduced hemolytic activity, or bacterial mutants lacking pneumolysin did not stimulate notable IL-1β production. We further found that NLRP3 was beneficial for mice during pneumonia caused by pneumococci expressing hemolytic pneumolysin, and was involved in cytokine production and maintenance of the pulmonary microvascular barrier. Overall, the inflammasome pathway is protective in pneumonia caused by pneumococci expressing hemolytic toxin, but is not activated by clinically important pneumococcal serotypes causing invasive disease in mice. The study indicates that a virulence factor polymorphism can substantially affect the recognition of bacteria by the innate immune system.
- 3 February 2011
- Published by Georg Thieme Verlag KG in Pneumologie
- Vol. 65 (02) , A11
The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia1
Streptococcus pneumoniae is a leading cause of pneumonia, meningitis and sepsis. While certain pneumococcal serotypes are associated with nasopharyngeal colonization, infections in patients with underlying diseases, and higher mortality when causing pneumonia, serotypes 1, 7F and 8 are predominantly found in invasive diseases that, however, show lower case-fatality rates. We tested the hypotheses that the innate immune inflammasome pathway is involved in fighting pneumococcal pneumonia, and that some invasive pneumococcal serotypes are not recognized by this pathway. We show that human and murine mononuclear cells responded to S. pneumoniae expressing hemolytic pneumolysin by producing IL-1β. This IL-1β production depended on the ‘NLR family, pyrin domain containing 3’ (NLRP3) inflammasome. Serotype 1, serotype 8 and serotype 7F bacteria producing toxins with no or reduced hemolytic activity, or bacterial mutants lacking pneumolysin did not stimulate notable IL-1β production. We further found that NLRP3 was beneficial for mice during pneumonia caused by pneumococci expressing hemolytic pneumolysin, and was involved in cytokine production and maintenance of the pulmonary microvascular barrier. Overall, the inflammasome pathway is protective in pneumonia caused by pneumococci expressing hemolytic toxin, but is not activated by clinically important pneumococcal serotypes causing invasive disease in mice. The study indicates that a virulence factor polymorphism can substantially affect the recognition of bacteria by the innate immune system.